BioNexus Gene Lab (BGLC) Institutional Ownership → Big Tech is spending billions each month on Nvidia’s AI superproject (From Weiss Ratings) (Ad) Free BGLC Stock Alerts $0.48 +0.00 (+1.01%) (As of 11:44 AM ET) Add Compare Share Share OwnershipStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for BioNexus Gene Lab (NASDAQ:BGLC)CurrentInstitutional OwnershipPercentage18.85%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$14.75KNumber ofInstitutional Sellers(last 12 months)0 Get BGLC Insider Trade Alerts Want to know when executives and insiders are buying or selling BioNexus Gene Lab stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Ad Weiss RatingsNvidia is now part of $3 Trillion Market Cap ClubA small handful of Nvidia’s partners could see their own stocks surge upwards. They’re virtually unknown right now, but that won’t be the case much longer.Click here to find out who they are today. BioNexus Gene Lab Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/20/2024 Virtu Financial LLC47,037$33K0.0%+79.9%0.266% (Data available from 1/1/2016 forward) BGLC Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of BGLC shares? During the previous two years, the following institutional investors and hedge funds held shares of BioNexus Gene Lab shares: Virtu Financial LLC ($33K).Learn more on BGLC's institutional investors. What percentage of BioNexus Gene Lab stock is owned by institutional investors? 18.85% of BioNexus Gene Lab stock is owned by institutional investors. Learn more on BGLC's institutional investor holdings. Which institutional investors have been buying BioNexus Gene Lab stock? The following institutional investors have purchased BioNexus Gene Lab stock in the last 24 months: Virtu Financial LLC ($20.89K). How much institutional buying is happening at BioNexus Gene Lab? Institutional investors have bought a total of 20,888 shares in the last 24 months. This purchase volume represents approximately $14.75K in transactions. Related Companies: PMD Major Shareholders DMTK Major Shareholders OPGN Major Shareholders ACON Major Shareholders NVTA Major Shareholders CNTG Major Shareholders LH Major Shareholders DGX Major Shareholders NTRA Major Shareholders EXAS Major Shareholders This page (NASDAQ:BGLC) was last updated on 6/13/2024 by MarketBeat.com Staff From Our PartnersThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredExecutive Order To Wipe Out Your Bank AccountsDon't wait until it's too late. The digital dollar is nearing the end of its trial period, and the window of o...Oasis Gold | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredGold Prices Surge and This $0.32 Stock Is Reaping The RewardsGold prices are on the rise. This surge in gold prices is great news for gold mining stocks. Especially ...Market JAR | SponsoredEstee Lauder, MAC, and other beauty brands are raving about this emerging NYSE AI companyA Little-known NYSE Company is Empowering the Beauty Industry with Innovative AI and AR Tools.Financial Markets Daily | SponsoredWall Street Icon: "I'd Put 50% of My Kids' Inheritance in THIS stock"Wall Street Icon Warns: "A Great Financial Reset is Underway" The man CNBC called "The Prophet" predicted t...Stansberry Research | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioNexus Gene Lab Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioNexus Gene Lab With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.